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Introduction 
The Medicines and Healthcare products Regulatory Agency (MHRA), the executive 
agency for the Department of Health (DoH) in England, ensures medicines and 
medical devices work and are safe. An incidence of fatal arterial embolism (AE) was 
reported, in which air was inadvertently injected into a patient rather than contrast 
media during a Computer Tomography (CT) examination with a contrast power 
injector pump. Instigating the issuing of safety notification MDA_SN_96261 
however this was withdrawn2 with the implication being that the equipment is safe 
and the incidence was human error.  
 
Venous Air Embolism 
Incidents of venous air embolism (VAE) occur when air enters the systemic venous 
system and travels to the lungs via the pulmonary arteries, where perfusion takes 
place to facilitate gas exchange3, causing bubbles to get lodged in the capillary bed 
disturbing normal gas exchange. This increases pulmonary arterial pressure, right 
ventricular strain, and cardiac arrhythmias. Leading to coronary artery occlusion, 
myocardial ischemia and ultimately cardiac failure.  Additional complications 
involve the disruption in pulmonary perfusion and ventilation creating alveolar 
dead space, hypoxia and hypercapnia4.  
 
Paradoxical AE can also occur mid or post procedure when VAE enters the arterial 
system through a patent foramen ovale, right to left shunts or arteriovenous 
malformation4. A systemic review by Mirski et al5 explained that a patent foramen 
ovale is present in approximately 20% of adults although a more reliable peer 
reviewed study by Hagen et al6 discussed autopsies of 965 specimens and 
evidenced a high level of 27.3%, and remains a significant risk factor of potential 
death resulting from VAE.  
 
What, Where, Why and How  
So what is the basic evidence do we know of to support these claims? Three 
significant physical law’s relating to VAE explain the behaviour of gases such as, 
Boyles’ Law, Henry’s Law and Hagen-Poiseuille's Law. 
 
 
Boyle’s Law explains if the temperature is constant, a fixed volume of gas is 
inversely proportional to the pressure applied7. For example, if the temperature of 
the contrast agent is constant, any volume of gas within the contrast will decrease 
as the power injector applies pressure on the liquid, i.e. as soon as the pressure 
decreases, the volume of the gas will increase when contrast reaches the lumen of 
the vessel.  
 
 
Henry’s Law affirms, the amount of air dissolved in a fluid is proportional to the 
pressure applied8. For example, air in the syringe will dissolve into the contrast 
when pressure is applied by the power injector and when depressurisation occurs 
in the lumen of the vessel air will release, akin to a bottle of fizzy drink.   
 
 
Hagen-Poiseuille's Law explains laminar flow in the vessel. Flow is proportional to 
the radius to power of 4 (r4) and inversely proportional to viscosity of the fluid and 
vessel length, meaning small changes to the diameter of the lumen of a vessel can 
make a large variation to the flow rate9.   
 
 
Detection  
So what studies, research or evidence is there out there? Due to the occult nature 
the majority of VAE are overlooked, go unreported and any adverse post injection 
incident can mimic cardiovascular conditions which can be nonspecific on clinical 
presentation, and the true incident may be underestimated. Episodes of iatrogenic 
VAE in CT contrast-enhanced imaging will inevitably go undetected when imaging 
other body regions, due to the area in which emboli occur not being demonstrated 
and therefore not reported, such as abdominal and pelvic scanning for example. 
 
Groell et al10 studied 677 patients, after vigilant injection technique of a 5ml saline 
flush and power injection of between 43-155ml of contrast agent, incidence of VAE 
was evident on contrast-enhanced images in 11.7% of patients.  
 
 
Image 1. Normal contrast in the left subclavian vein 
 
 
Image 2. VAE in the left subclavian vein 
 
What size bubble is trouble?   
In a study on dogs Durant et al11 established the volume of air, rate of injection and 
patient position were all factors influencing production of VAE. The amount of air 
required to cause fatality was extremely variable; 25-150 ml of air was tolerated 
but more recent case reports show in humans a power injected non-fatal volume of 
135ml12. Toung et al13 estimates the lethal volume of air in humans to be 200ml, 
however the definitive fatal volume remains unknown. 
 
Conclusion  
The DOH is in consultation to make intravenous AE within healthcare a “Never 
Event”. To qualify, the event has to:-  
- Have the potential to cause harm or death  
- Have national guidance for prevention and if followed the event is preventable.  
- Has to be easily defined.  
-  
Occurrence of such an event indicates an organisation has failed to prevent it and 
failed to prevent harm to the patient. If AE becomes a “Never Event”, prevention of 
VAE will require a more stringent approach than currently practiced and it also has 
financial implications to healthcare providers as any associated costs resulting from 
a “Never Event” have to be borne by the provider14.   
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